产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 原料药 Enoxaparin sodi...

Enoxaparin sodium

2025-02-07
9005-49-6
企业标准
Medicine Grade

产品详情

Enoxaparin sodium
心血管系统用药
9005-49-6
企业标准
Medicine Grade
北美洲,西欧,东欧,亚洲,中东,非洲

产品描述

Category: API

Introduction: It can be used for:

1. Prevention of thrombus: during those surgical operation such as displacement of hip joint, knee joint and percutaneous coronary intervention (PCI), heparin can be used to prevent thrombus mainly including deep venous thrombosis and lung thrombosis;

2. Prevention and treatment of thrombotic disease: such as miocardial infarction, unstable angina and apoplexy and so on.       

3. Treatment of disseminated intravascular coagulation (DIC) caused by all kinds diseases.

4. Anticoagulant outside body: hematodialysis, blood bank, extracorporeal circulation, blood sample and intravascular stent and so on.

Character: Characters hygroscopic, white or almost white power

Applications: Pharmaceutical raw materials

Place of Origin: China

Quality Specification: Please contact Baiyu for updated version COA

四川宏明博思药业有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

四川宏明博思药业有限公司成立于2013年,专注于原料药和制剂的生产。现有员工400余人,主要生产高端剂型如注射剂、冻干粉针剂、片剂和胶囊剂。宏明博思的冻干粉针制剂生产线已获得EU GMP,并通过巴西ANVISA现场检查。目前四川宏明博思冻干粉针制剂的多个产品在巴西、智利、秘鲁、危地马拉、泰国、菲律宾、马来西亚、南非、澳大利亚等开展注册中。Sichuan Omnis Pharmaceutical Co., Ltd. was established in 2013, focusing on the manufacture of FDFs and APIs, located in Sichuan Chengdu, China. It currently has more than 400 employees and mainly produces high-end dosage forms such as injections, lyophilized powder injections, tablets and capsules. Omnis has granted China/EU/ANVISA/PICs GMP for lyophilized powder injection line. Currently, multiple products of lyophilized powder injection are undergoing registration in Brazil, Chile, Peru, Guatemala, Thailand, the Philippines, Malaysia, South Africa, Australia, and other countries.
业务类型:
成立日期:
年营业额:
主营产品类别: